Life Science Investing KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE® Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025
Life Science Investing KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance
Life Science Investing KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems
Life Science Investing KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025
Life Science Investing ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy
LAURION Broadens Advisor Network and Issues Stock Options to First Nations under Amended Exploration Agreement as Ishkoday Exploration Progresses
